Subscribe to our Newsletters !!


    Stage III preliminary of Oxford antibody to start in Pune one week from now

    Pune, Sep 19 (PTI) The phase-III human clinical trial of the COVID-19 vaccine developed by Oxford University and being fabricated by the Serum Institute of India (SII) will begin at the Sassoon General Hospital in Pune next week. “The phase-III trial of”Covishield” vaccine will start in Sassoon hospital from next week. It’s likely to start

    AstraZeneca gets halfway invulnerability in ease EU antibody bargain

    European authorities will pay claims over an agreed limit against AstraZeneca over side-effects from its potential COVID-19 vaccine, under different terms to a deal struck with Sanofi, an EU official told Reuters. The deals reflect different approaches by two of the world’s best drugmakers for protecting themselves as a debate rages about liabilities for vaccines